236 related articles for article (PubMed ID: 31400953)
1. Dosimetric and radiobiological investigation of permanent implant prostate brachytherapy based on Monte Carlo calculations.
Haidari AM; Miksys N; Soubiran P; Cygler JE; Holmes O; Perry G; Thomson RM
Brachytherapy; 2019; 18(6):875-882. PubMed ID: 31400953
[TBL] [Abstract][Full Text] [Related]
2. Coupling I-125 permanent implant prostate brachytherapy Monte Carlo dose calculations with radiobiological models.
Miksys N; Haidari M; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Med Phys; 2017 Aug; 44(8):4329-4340. PubMed ID: 28455849
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of dosimetric effects of metallic artifact reduction and tissue assignment on Monte Carlo dose calculations for
Assam I; Vijande J; Ballester F; Pérez-Calatayud J; Poppe B; Siebert FA
Med Phys; 2022 Sep; 49(9):6195-6208. PubMed ID: 35925023
[TBL] [Abstract][Full Text] [Related]
4. Investigation of interseed attenuation and tissue composition effects in (125)I seed implant prostate brachytherapy.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Brachytherapy; 2014; 13(6):603-10. PubMed ID: 24913435
[TBL] [Abstract][Full Text] [Related]
5. Performance evaluation of a collapsed cone dose calculation algorithm for HDR Ir-192 of APBI treatments.
Terribilini D; Vitzthum V; Volken W; Frei D; Loessl K; van Veelen B; Manser P; Fix MK
Med Phys; 2017 Oct; 44(10):5475-5485. PubMed ID: 28750134
[TBL] [Abstract][Full Text] [Related]
6. Large-scale Retrospective Monte Carlo Dosimetric Study for Permanent Implant Prostate Brachytherapy.
Miksys N; Vigneault E; Martin AG; Beaulieu L; Thomson RM
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):606-615. PubMed ID: 28126308
[TBL] [Abstract][Full Text] [Related]
7. Consequences of dose heterogeneity on the biological efficiency of ¹⁰³Pd permanent breast seed implants.
Afsharpour H; Reniers B; Landry G; Pignol JP; Keller BM; Verhaegen F; Beaulieu L
Phys Med Biol; 2012 Feb; 57(3):809-23. PubMed ID: 22252246
[TBL] [Abstract][Full Text] [Related]
8. Quantifying the effect of seed orientation in postplanning dosimetry of low-dose-rate prostate brachytherapy.
Collins Fekete CA; Plamondon M; Martin AG; Vigneault É; Verhaegen F; Beaulieu L
Med Phys; 2014 Oct; 41(10):101704. PubMed ID: 25281943
[TBL] [Abstract][Full Text] [Related]
9. Monte Carlo investigation of I-125 interseed attenuation for standard and thinner seeds in prostate brachytherapy with phantom validation using a MOSFET.
Mason J; Al-Qaisieh B; Bownes P; Henry A; Thwaites D
Med Phys; 2013 Mar; 40(3):031717. PubMed ID: 23464312
[TBL] [Abstract][Full Text] [Related]
10. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
[TBL] [Abstract][Full Text] [Related]
11. The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy.
Duque AS; Corradini S; Kamp F; Seidensticker M; Streitparth F; Kurz C; Walter F; Parodi K; Verhaegen F; Ricke J; Belka C; Fonseca GP; Landry G
Radiat Oncol; 2020 Mar; 15(1):60. PubMed ID: 32151255
[TBL] [Abstract][Full Text] [Related]
12. Monte Carlo study of LDR seed dosimetry with an application in a clinical brachytherapy breast implant.
Furstoss C; Reniers B; Bertrand MJ; Poon E; Carrier JF; Keller BM; Pignol JP; Beaulieu L; Verhaegen F
Med Phys; 2009 May; 36(5):1848-58. PubMed ID: 19544804
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo investigation of dose distribution of uniformly and non-uniformly loaded standard and notched eye plaques.
Semeniuk O; Malkov V; Chamberland MJP; Weersink RA
J Appl Clin Med Phys; 2023 Dec; 24(12):e14149. PubMed ID: 37738654
[TBL] [Abstract][Full Text] [Related]
14. A detailed radiobiological and dosimetric analysis of biochemical outcomes in a case-control study of permanent prostate brachytherapy patients.
Butler WM; Stewart RR; Merrick GS
Med Phys; 2009 Mar; 36(3):776-87. PubMed ID: 19378738
[TBL] [Abstract][Full Text] [Related]
15. Dosimetric investigation of
Deering SG; Hilts M; Batchelar D; Crook J; Thomson RM
Brachytherapy; 2021; 20(3):686-694. PubMed ID: 33551273
[TBL] [Abstract][Full Text] [Related]
16. Calcifications in low-dose rate prostate seed brachytherapy treatment: post-planning dosimetry and predictive factors.
Collins Fekete CA; Plamondon M; Martin AG; Vigneault É; Verhaegen F; Beaulieu L
Radiother Oncol; 2015 Mar; 114(3):339-44. PubMed ID: 25702862
[TBL] [Abstract][Full Text] [Related]
17. A Monte Carlo dose recalculation pipeline for durable datasets: an I-125 LDR prostate brachytherapy use case.
Ouellet S; Lemaréchal Y; Berumen-Murillo F; Lavallée MC; Vigneault É; Martin AG; Foster W; Thomson RM; Després P; Beaulieu L
Phys Med Biol; 2023 Nov; 68(23):. PubMed ID: 37863069
[TBL] [Abstract][Full Text] [Related]
18. Dose escalation in permanent brachytherapy for prostate cancer: dosimetric and biological considerations.
Li XA; Wang JZ; Stewart RD; DiBiase SJ
Phys Med Biol; 2003 Sep; 48(17):2753-65. PubMed ID: 14516099
[TBL] [Abstract][Full Text] [Related]
19. Development of virtual patient models for permanent implant brachytherapy Monte Carlo dose calculations: interdependence of CT image artifact mitigation and tissue assignment.
Miksys N; Xu C; Beaulieu L; Thomson RM
Phys Med Biol; 2015 Aug; 60(15):6039-62. PubMed ID: 26216174
[TBL] [Abstract][Full Text] [Related]
20. Dosimetry modeling for focal high-dose-rate prostate brachytherapy.
Mason J; Al-Qaisieh B; Bownes P; Thwaites D; Henry A
Brachytherapy; 2014; 13(6):611-7. PubMed ID: 25085456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
